News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TPG-Backed Quintiles, Inc. (QTRN) Outlines $790 Million Price in IPO


4/26/2013 8:25:47 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Quintiles Transnational Holdings Inc., the biggest provider of testing services to drugmakers, filed to raise about $790 million in a U.S. initial public offering. The company and its shareholders, including TPG Capital and Bain Capital LLC, are offering 19.7 million shares for $36 to $40 apiece, according to a regulatory filing today. That would be equal to about 15 percent of the shares outstanding. At the midpoint of the range, the market value for Quintiles would be about $4.9 billion, according to data compiled by Bloomberg. It joins companies including ING U.S. Inc. that are selling shares this year after U.S. stocks have risen to record levels and volatility in the market has subsided.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Nasdaq
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES